IN8bio Financials - Benzinga

IN8bio Inc

INABNASDAQ

Trade with Public

Trade with Public

$0.9786

0.00870.9%

At close: Aug 7, 5:00 PM EST

$0.9786

N/A

After Hours: Aug 7, 5:09 PM EST

Earnings: Q2 2026 Earnings were released on Thu Aug 6th, after the market close

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

IN8bio Financials

IN8bio (INAB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
IN8bio Q2 EPS $(0.25) Beats $(0.37) Estimate

IN8bio (NASDAQ:INAB) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.37) by 32.43 percent. This is a 79.84 percent increase over losses of $(1.24) per share from the same

Benzinga Newsdesk

PRO
IN8bio Q1 EPS $(0.26) Beats $(0.69) Estimate

IN8bio (NASDAQ:INAB) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.69) by 62.32 percent. This is a 87.96 percent increase over losses of $(2.16) per share from the same

Benzinga Newsdesk

PRO
IN8bio Q4 EPS $(0.26) Beats $(0.51) Estimate

Benzinga Newsdesk

PRO
IN8bio Q3 EPS $(0.85) Beats $(1.25) Estimate

Benzinga Newsdesk

PRO
IN8bio Q2 EPS $(1.24) Beats $(1.70) Estimate

IN8bio (NASDAQ:INAB) reported quarterly losses of $(1.24) per share which beat the analyst consensus estimate of $(1.70) by 27.06 percent. This is a 78.25 percent increase over losses of $(5.70) per share from the same

Benzinga Newsdesk

PRO
IN8bio Q1 EPS $(0.07), Inline

IN8bio (NASDAQ:INAB) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is a 65 percent increase over losses of $(0.20) per share from the same period last year.

Benzinga Newsdesk